Evidence-based use of second-generation antipsychotics in a state Medicaid pediatric population, 2001-2005. [electronic resource]
Producer: 20100503Description: 123-9 p. digitalISSN:- 1557-9700
- Adolescent
- Antipsychotic Agents -- adverse effects
- Aripiprazole
- Benzodiazepines -- adverse effects
- Child
- Child, Preschool
- Clozapine -- adverse effects
- Dibenzothiazepines -- adverse effects
- Drug Utilization -- statistics & numerical data
- Evidence-Based Medicine
- Female
- Humans
- Infant
- Insurance Claim Review
- Male
- Medicaid
- Mental Disorders -- drug therapy
- Off-Label Use
- Olanzapine
- Piperazines -- adverse effects
- Quetiapine Fumarate
- Quinolones -- adverse effects
- Risperidone -- adverse effects
- Thiazoles -- adverse effects
- United States
- United States Food and Drug Administration
No physical items for this record
Publication Type: Journal Article
There are no comments on this title.
Log in to your account to post a comment.